Cresco Labs (CRLBF) Non-Current Deferred Tax Liability (2019 - 2025)

Cresco Labs' Non-Current Deferred Tax Liability history spans 7 years, with the latest figure at $76.9 million for Q4 2025.

  • For Q4 2025, Non-Current Deferred Tax Liability fell 8.59% year-over-year to $76.9 million; the TTM value through Dec 2025 reached $76.9 million, down 8.59%, while the annual FY2025 figure was $76.9 million, 8.59% down from the prior year.
  • Non-Current Deferred Tax Liability reached $76.9 million in Q4 2025 per CRLBF's latest filing, down from $84.2 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $89.4 million in Q4 2023 to a low of $75.1 million in Q4 2022.
  • Average Non-Current Deferred Tax Liability over 5 years is $82.3 million, with a median of $84.2 million recorded in 2024.
  • Peak YoY movement for Non-Current Deferred Tax Liability: skyrocketed 107.92% in 2021, then decreased 12.29% in 2022.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $85.7 million in 2021, then decreased by 12.29% to $75.1 million in 2022, then grew by 18.99% to $89.4 million in 2023, then fell by 5.86% to $84.2 million in 2024, then decreased by 8.59% to $76.9 million in 2025.
  • Per Business Quant, the three most recent readings for CRLBF's Non-Current Deferred Tax Liability are $76.9 million (Q4 2025), $84.2 million (Q4 2024), and $89.4 million (Q4 2023).